Search Results

PHA-680632 50mg 50mg  | Purity Not Available

Adooq Bioscience

PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.

More Information Supplier Page

PHA-680632 5mg 5mg  | Purity Not Available

Adooq Bioscience

PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.

More Information Supplier Page

PHA-680632 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.

More Information Supplier Page

PHA-680632 100mg 100mg  | Purity Not Available

Adooq Bioscience

PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.

More Information Supplier Page

PHA-680632 10mg 10mg  | Purity Not Available

Adooq Bioscience

PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.

More Information Supplier Page

Danusertib 5mg 5mg  | Purity Not Available

Adooq Bioscience

Danusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor

More Information Supplier Page

Danusertib 50mg 50mg  | Purity Not Available

Adooq Bioscience

Danusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor

More Information Supplier Page